Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.
The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients / B. Alman, S. Attia, C. Baumgarten, C. Benson, J.-. Blay, S. Bonvalot, J. Breuing, K. Cardona, P.G. Casali, F. van Coevorden, C. Colombo, A.P. Dei Tos, P. Dileo, A. Ferrari, M. Fiore, A.M. Frezza, J. Garcia, R. Gladdy, M. Gounder, A. Gronchi, R. Haas, S. Hackett, F. Haller, P. Hohenberger, O. Husson, R.L. Jones, I. Judson, B. Kasper, A. Kawai, V. Kogosov, A.J. Lazar, R. Maki, T. Mathes, C. Messiou, F. Navid, Y. Nishida, E. Palassini, N. Penel, R. Pollock, D. Pieper, M. Portnoy, C.P. Raut, E. Roets, S. Sandrucci, M. Sbaraglia, S. Stacchiotti, K.A. Thornton, W. van der Graaf, K. van der Zande, W.J. van Houdt, V. Villalobos, A.J. Wagner, E. Wardelmann, M. Wartenberg, S. Watson, A. Weiss, N. Zafiropoulos. - In: EUROPEAN JOURNAL OF CANCER. - ISSN 0959-8049. - 127(2020), pp. 96-107. [10.1016/j.ejca.2019.11.013]
The management of desmoid tumours : A joint global consensus-based guideline approach for adult and paediatric patients
P.G. Casali;
2020
Abstract
Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0959804919308329.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
1.07 MB
Formato
Adobe PDF
|
1.07 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
